• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多功能纳米平台介导的化疗-光热治疗联合免疫原性细胞死亡和检查点阻断治疗三阴性乳腺癌及远处转移

Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.

机构信息

Department of Ultrasound, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

Chongqing Key Laboratory of Ultrasound Molecular Imaging, Chongqing Medical University, Chongqing, People's Republic of China.

出版信息

Int J Nanomedicine. 2023 Jun 9;18:3109-3124. doi: 10.2147/IJN.S408855. eCollection 2023.

DOI:10.2147/IJN.S408855
PMID:37323948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10265501/
Abstract

BACKGROUND

Breast cancer has become the most common cancer in women. Compare with other subtypes of breast cancer, triple-negative breast cancer (TNBC) is more likely to relapse and metastasize. Highly effective therapeutic strategies are desperately needed to be explored. In this study, a multifunctional nanoplatform is expected to mediate chemo-photothermal therapy, which can combine immunogenic cell death with checkpoint blockade to combat TNBC and distant metastasis.

METHODS

Poly (lactic acid-glycolic acid)-Poly (ethylene glycol) (PLGA-PEG) nanoparticles (NPs), a type of polymeric NPs, loaded with IR780, a near-infrared (NIR) dye, and doxorubicin (DOX) as the chemotherapeutic drug, were assembled by an improved double emulsification method (designated as IDNPs). The characterization, intracellular uptake, biosafety, photoacoustic (PA) imaging performance, and biodistribution of IDNPs were studied. Chemo-photothermal therapeutic effect and immunogenic cell death (ICD) were evaluated both in vitro and in vivo. The potency of chemo-photothermal therapy-triggered ICD in combination with anti-PD-1 immune checkpoint blockade (ICB) immunotherapy in eliciting immune response and treating distant tumors was further investigated.

RESULTS

IR780 and DOX were successfully loaded into PLGA-PEG to form the IDNPs, with size of 243.87nm and Zeta potential of -6.25mV. The encapsulation efficiency of IR780 and DOX was 83.44% and 5.98%, respectively. IDNPs demonstrated remarkable on-site accumulation and PA imaging capability toward 4T1 TNBC models. Chemo-photothermal therapy demonstrated satisfactory therapeutic effects both in vitro and in vivo, and triggered ICD efficiently. ICD, in combination with anti-PD-1, provoked a systemic antitumor immune response against distant tumors.

CONCLUSION

Multifunctional IDNPs were successfully synthesized to mediate chemo-photothermal therapy, which combines immunogenic cell death with checkpoint blockade to combat TNBC and distant metastasis, showing great promise preclinically and clinically.

摘要

背景

乳腺癌已成为女性最常见的癌症。与其他乳腺癌亚型相比,三阴性乳腺癌(TNBC)更容易复发和转移。迫切需要探索更有效的治疗策略。在这项研究中,期望一种多功能纳米平台能够介导化疗-光热治疗,将免疫原性细胞死亡与检查点阻断相结合,以治疗 TNBC 和远处转移。

方法

聚(乳酸-乙醇酸)-聚(乙二醇)(PLGA-PEG)纳米粒子(NPs),一种聚合物 NPs,负载近红外(NIR)染料 IR780 和阿霉素(DOX)作为化疗药物,通过改进的双乳化法(命名为 IDNPs)组装而成。研究了 IDNPs 的表征、细胞内摄取、生物安全性、光声(PA)成像性能和体内分布。在体外和体内评估了化疗-光热治疗效果和免疫原性细胞死亡(ICD)。进一步研究了化疗-光热治疗触发的 ICD 与抗 PD-1 免疫检查点阻断(ICB)免疫治疗联合在引发免疫反应和治疗远处肿瘤方面的效果。

结果

IR780 和 DOX 成功负载到 PLGA-PEG 中形成 IDNPs,粒径为 243.87nm,Zeta 电位为-6.25mV。IR780 和 DOX 的包封效率分别为 83.44%和 5.98%。IDNPs 对 4T1 TNBC 模型表现出显著的原位积累和 PA 成像能力。化疗-光热治疗在体外和体内均显示出令人满意的治疗效果,并有效地触发了 ICD。ICD 与抗 PD-1 联合使用,引发了针对远处肿瘤的全身性抗肿瘤免疫反应。

结论

成功合成了多功能 IDNPs 来介导化疗-光热治疗,将免疫原性细胞死亡与检查点阻断相结合,以治疗 TNBC 和远处转移,在临床前和临床方面都显示出巨大的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/447cf0a997cd/IJN-18-3109-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/ce76c82e108f/IJN-18-3109-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/8103f70e2247/IJN-18-3109-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/eec7c8bc4dff/IJN-18-3109-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/2a166da54588/IJN-18-3109-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/3cdeab1de6cb/IJN-18-3109-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/07f3492e6e06/IJN-18-3109-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/43892824236d/IJN-18-3109-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/447cf0a997cd/IJN-18-3109-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/ce76c82e108f/IJN-18-3109-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/8103f70e2247/IJN-18-3109-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/eec7c8bc4dff/IJN-18-3109-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/2a166da54588/IJN-18-3109-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/3cdeab1de6cb/IJN-18-3109-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/07f3492e6e06/IJN-18-3109-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/43892824236d/IJN-18-3109-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/10265501/447cf0a997cd/IJN-18-3109-g0008.jpg

相似文献

1
Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.多功能纳米平台介导的化疗-光热治疗联合免疫原性细胞死亡和检查点阻断治疗三阴性乳腺癌及远处转移
Int J Nanomedicine. 2023 Jun 9;18:3109-3124. doi: 10.2147/IJN.S408855. eCollection 2023.
2
In situ Injection of pH- and Temperature-Sensitive Nanomaterials Increases Chemo-Photothermal Efficacy by Alleviating the Tumor Immunosuppressive Microenvironment.原位注射 pH 和温度敏感型纳米材料通过减轻肿瘤免疫抑制微环境增强化学-光热疗效。
Int J Nanomedicine. 2022 Jun 16;17:2661-2678. doi: 10.2147/IJN.S367121. eCollection 2022.
3
Thermo- and pH-dual responsive polymeric micelles with upper critical solution temperature behavior for photoacoustic imaging-guided synergistic chemo-photothermal therapy against subcutaneous and metastatic breast tumors.具有上临界溶液温度行为的温敏和 pH 双重响应聚合物胶束用于光声成像引导的协同化学-光热治疗皮下和转移性乳腺癌。
Theranostics. 2018 Jul 16;8(15):4097-4115. doi: 10.7150/thno.26195. eCollection 2018.
4
A Multifunctional, Highly Biocompatible, and Double-Triggering Caramelized Nanotheranostic System Loaded with FeO and DOX for Combined Chemo-Photothermal Therapy and Real-Time Magnetic Resonance Imaging Monitoring of Triple Negative Breast Cancer.一种多功能、高生物相容性、双触发的焦糖化纳米诊疗系统,负载 FeO 和 DOX,用于三阴性乳腺癌的联合化疗-光热治疗和实时磁共振成像监测。
Int J Nanomedicine. 2023 Feb 19;18:881-897. doi: 10.2147/IJN.S393507. eCollection 2023.
5
Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.金属有机框架介导的多功能纳米颗粒用于结直肠癌的联合化疗-光热治疗和增强免疫治疗。
Acta Biomater. 2022 May;144:132-141. doi: 10.1016/j.actbio.2022.03.023. Epub 2022 Mar 18.
6
Photothermal MnO nanoparticles boost chemo-photothermal therapy-induced immunogenic cell death in tumor immunotherapy.光热 MnO 纳米颗粒增强化疗-光热治疗诱导的肿瘤免疫治疗中的免疫原性细胞死亡。
Int J Pharm. 2022 Apr 5;617:121578. doi: 10.1016/j.ijpharm.2022.121578. Epub 2022 Feb 14.
7
A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.一种光控的靶向双模态成像引导光热/化疗协同治疗的特异药物递送纳米平台。
Acta Biomater. 2018 Oct 15;80:308-326. doi: 10.1016/j.actbio.2018.09.024. Epub 2018 Sep 19.
8
Photothermal Ferrotherapy - Induced Immunogenic Cell Death via Iron-Based Ternary Chalcogenide Nanoparticles Against Triple-Negative Breast Cancer.光热铁疗——基于铁基三元硫属化物纳米颗粒诱导免疫原性细胞死亡治疗三阴性乳腺癌。
Small. 2024 May;20(20):e2306766. doi: 10.1002/smll.202306766. Epub 2023 Dec 14.
9
A multifunctional nanodiamond-based nanoplatform for the enhanced mild-temperature photothermal/chemo combination therapy of triple negative breast cancer via an autophagy regulation strategy.一种基于多功能纳米金刚石的纳米平台,通过自噬调控策略增强三阴性乳腺癌的温和温度光热/化疗联合治疗。
Nanoscale. 2021 Aug 21;13(31):13375-13389. doi: 10.1039/d1nr03161a. Epub 2021 Jul 28.
10
Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.载双化疗药物的单壁碳纳米角用于肿瘤及肺转移的多模态成像引导化疗-光热治疗
Theranostics. 2018 Feb 15;8(7):1966-1984. doi: 10.7150/thno.23848. eCollection 2018.

引用本文的文献

1
Reprogramming the tumor-immune landscape via nanomaterial-induced immunogenic cell death: a mini review.通过纳米材料诱导的免疫原性细胞死亡重编程肿瘤免疫格局:一篇综述。
Front Bioeng Biotechnol. 2025 Jul 22;13:1635747. doi: 10.3389/fbioe.2025.1635747. eCollection 2025.
2
Advancements in Nano-Delivery Systems for Photodynamic and Photothermal Therapy to Induce Immunogenic Cell Death in Tumor Immunotherapy.用于光动力和光热疗法的纳米递送系统在肿瘤免疫治疗中诱导免疫原性细胞死亡的研究进展。
Int J Nanomedicine. 2025 Jun 26;20:8221-8248. doi: 10.2147/IJN.S514659. eCollection 2025.
3
Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer.

本文引用的文献

1
Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative "cold" triple-negative breast cancer.吉西他滨与紫杉醇联合纳米CpG共递送增强术后“冷”三阴性乳腺癌的化学免疫治疗。
Bioact Mater. 2023 Jan 22;25:61-72. doi: 10.1016/j.bioactmat.2023.01.014. eCollection 2023 Jul.
2
Functionalized liposomes for targeted breast cancer drug delivery.用于靶向乳腺癌药物递送的功能化脂质体。
Bioact Mater. 2023 Jan 2;24:401-437. doi: 10.1016/j.bioactmat.2022.12.027. eCollection 2023 Jun.
3
Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.
用于三阴性乳腺癌化学/光/免疫治疗的时空可控活性氧响应型喜树碱纳米炸弹
J Nanobiotechnology. 2024 Dec 27;22(1):798. doi: 10.1186/s12951-024-03050-x.
4
Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects.药物介导的 ICD 抑制乳腺癌的综合综述:机制、现状与展望。
Clin Exp Med. 2024 Sep 26;24(1):230. doi: 10.1007/s10238-024-01482-1.
5
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer.纳米颗粒介导的免疫疗法在三阴性乳腺癌中的应用。
ACS Biomater Sci Eng. 2024 Jun 10;10(6):3568-3598. doi: 10.1021/acsbiomaterials.4c00108. Epub 2024 May 30.
6
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot.免疫原性细胞死亡诱导剂在癌症免疫治疗中的临床应用:将冷肿瘤变热
Front Cell Dev Biol. 2024 May 7;12:1363121. doi: 10.3389/fcell.2024.1363121. eCollection 2024.
通过引发细胞焦亡和免疫反应对抗乳腺癌的无载体纳米平台
ACS Appl Mater Interfaces. 2023 Jan 11;15(1):452-468. doi: 10.1021/acsami.2c17579. Epub 2022 Dec 20.
4
IL-5-producing CD4 T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.产生 IL-5 的 CD4 T 细胞和嗜酸性粒细胞共同作用,增强乳腺癌对免疫检查点阻断的反应。
Cancer Cell. 2023 Jan 9;41(1):106-123.e10. doi: 10.1016/j.ccell.2022.11.014. Epub 2022 Dec 15.
5
A novel structurally identified epitope delivered by macrophage membrane-coated PLGA nanoparticles elicits protection against Pseudomonas aeruginosa.一种新型结构鉴定的表位,由巨噬细胞膜包裹的 PLGA 纳米颗粒递呈,可诱导机体抵抗铜绿假单胞菌。
J Nanobiotechnology. 2022 Dec 14;20(1):532. doi: 10.1186/s12951-022-01725-x.
6
HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy.肝肾功能综合征调节小细胞外囊泡程序性死亡配体-1的分泌,并与抗程序性死亡蛋白1治疗疗效相关。
Cancer Immunol Res. 2023 Feb 3;11(2):228-240. doi: 10.1158/2326-6066.CIR-22-0277.
7
NIR-triggered ligand-presenting nanocarriers for enhancing synergistic photothermal-chemotherapy.用于增强光热-化疗协同作用的近红外触发配体呈现纳米载体
J Control Release. 2023 Jan;353:229-240. doi: 10.1016/j.jconrel.2022.11.039. Epub 2022 Nov 25.
8
Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: A double-blind, randomized, placebo-controlled trial.局部应用褪黑素治疗早期乳腺癌急性放射性皮炎对生活质量的影响:一项双盲、随机、安慰剂对照试验。
J Pineal Res. 2023 Jan;74(1):e12840. doi: 10.1111/jpi.12840. Epub 2022 Nov 24.
9
Versatile Red Blood Cells for Triple-Negative Breast Cancer Treatment via Stepwise Photoactivations.多功能红细胞通过逐步光激活用于三阴性乳腺癌治疗。
Adv Healthc Mater. 2023 Jan;12(3):e2201690. doi: 10.1002/adhm.202201690. Epub 2022 Nov 4.
10
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy.三阴性乳腺癌中的铁死亡异质性揭示了一种创新的免疫治疗联合策略。
Cell Metab. 2023 Jan 3;35(1):84-100.e8. doi: 10.1016/j.cmet.2022.09.021. Epub 2022 Oct 17.